trending Market Intelligence /marketintelligence/en/news-insights/trending/s4ohetxrfrrtb6xtz10usq2 content esgSubNav
In This List

Allergan appoints board member

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Allergan appoints board member

Allergan PLC appointed Thomas Freyman to the board, effective June 14.

Freyman was executive vice president of finance and administration at Abbott Laboratories.

In addition, the Irish pharmaceutical giant said Patrick O'Sullivan will retire from the board in July. O'Sullivan has served on the board since 2013, when Allergan acquired Warner Chilcott PLC.

Allergan's board will continue to have 12 members after O'Sullivan's retirement and the addition of Freyman.